Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

4,646 total articles

Protagonist Therapeutics Director Executes Option and Sells $2.52M in Stock After FDA Nod for Icotyde

Protagonist Therapeutics Director Executes Option and Sells $2.52M in Stock After FDA Nod for Icotyde

Protagonist Therapeutics director Harold E. Selick exercised options to buy 24,000 shares at $12.88 and sold those shares along with an additional 24,000 shares on March 26, 2026, generating proceeds of $2.52 million from the stock sale and $309,120 tied to the option exercise. The share transactions occurred with the stock trading near its 52-week…

Protagonist CMO Sells $1.57M in Stock After Option Exercise as Icotyde Approval Spurs Analyst Upgrades

Protagonist CMO Sells $1.57M in Stock After Option Exercise as Icotyde Approval Spurs Analyst Upgrades

Arturo Molina, M.D., the chief medical officer of Protagonist Therapeutics (PTGX), sold 15,000 shares of common stock on March 26, 2026, generating about $1.57 million. Molina also exercised options to acquire 15,000 shares at $8.04. The trades come as Protagonist shares have climbed sharply following FDA approval of Icotyde (icotrokinra), promptin…

Indie Semiconductor CEO Executes $153K Sale Under 10b5-1 Plan as Company Advances Product and Financing Plans

Indie Semiconductor CEO Executes $153K Sale Under 10b5-1 Plan as Company Advances Product and Financing Plans

Indie Semiconductor Chief Executive Officer Donald McClymont sold 50,000 shares of Class A common stock on March 25, 2026, for about $153,110 under a Rule 10b5-1 trading plan. The company concurrently disclosed a product milestone in ultraviolet laser diodes for quantum computing, planned convertible note offerings due 2031, and a new in-cabin moni…

Willis Lease Executive Chairman Disposes $2.74M in Company Stock

Willis Lease Executive Chairman Disposes $2.74M in Company Stock

Charles F. Willis IV, executive chairman of Willis Lease Finance Corp, sold 15,031 shares of company common stock between March 25 and March 27, 2026, generating roughly $2.74 million in proceeds. The transactions span prices from $168.023 to $177.567. The stock has dipped modestly over the past week, while external analysis cited in company resear…

Star Equity Director Louis A. Parks Adds $15,015 to Stake as Company Advances Repurchase and Compensation Moves

Star Equity Director Louis A. Parks Adds $15,015 to Stake as Company Advances Repurchase and Compensation Moves

Louis A. Parks, a director at Star Equity Holdings, Inc. (NASDAQ:STRR), purchased 1,500 shares on March 27, 2026, at $10.01 per share, investing $15,015. The transaction follows a March 25, 2026, settlement of 417 restricted stock units and comes amid company-initiated share repurchase activity, executive compensation revisions and a recent sale-le…

Kratos KTT President Disposes of 4,000 Shares in Planned 10b5-1 Sale

Kratos KTT President Disposes of 4,000 Shares in Planned 10b5-1 Sale

Stacey G. Rock, president of Kratos Defense & Security Solutions' KTT Division, executed a prearranged 10b5-1 plan sale of 4,000 Kratos (NASDAQ:KTOS) shares on March 26, 2026, raising $307103. The sale occurred in three tranches at prices between $75.6187 and $78.4865. Post-transaction, Rock directly holds 21,777 Kratos shares. Separately, Kratos a…

NextNav Chief Accounting Officer Disposes $77,085 in Stock

NextNav Chief Accounting Officer Disposes $77,085 in Stock

NextNav Inc. (NASDAQ: NN) Chief Accounting Officer Shams Sammaad sold 3,945 shares on March 26, 2026, at $19.54 per share, generating $77,085. The trade occurred close to the stock's 52-week high and followed a 37% rise over the past year. InvestingPro data highlights substantial operating losses for NextNav, noting a negative gross profit margin o…